Investor Summary

The fund is co-managed by Ben Ridley (Head of Equities, joined February 2024) and Elliot Farley (Co-Manager since 2011, with funds since 2000). Ben brings 25 years of experience managing global equity funds at TT International, Meditor Capital, Morgan Stanley and M&G, with a master's degree in Politics from the University of Edinburgh, IIMR qualification, CISI membership, and completed CFA UK program. He is an experienced investor with a demonstrable long-term track record of alpha generation. Elliot has been instrumental in refining the investment process of the T. Bailey funds over more than two decades, was previously an ACA with Deloitte & Touche, and is a Warwick University Mathematics graduate. T. Bailey Asset Management is a family-run investment company established in 1999 with over 20 years of successful investing, privately owned and proudly independent, extending from managing family investments to serving other investors.

Read More

Fund Strategy

T. Bailey are thematic investors believing that companies demonstrating good governance, environmental concern and societal good will be long-term winners. Their key objective is achieving the best possible risk-adjusted returns for investors. They are privately owned, proudly independent and focused, without compromise, on preserving and growing investors' wealth. Thematic investing focuses on investments where demand is robust and likely to exceed supply over the foreseeable future. They favour global themes spotlighting higher growth opportunities irrespective of geography. Their geographic allocation is a fall-out from their thematic approach not a driver of it. The fund focuses on four key investment themes: Demographics (aging populations, consumption changes, inequality, education, evolving work practices), Finite Resources (decarbonisation, climate change, energy transition, advanced materials, efficient agriculture, energy storage, 21st-century infrastructure), Innovation (automation, robotics, digitisation, artificial intelligence, data handling, blockchain and tokenisation, supply chain resilience), and Healthcare (genomics, nutrition, drug discovery, personalised medicine, health monitoring, delivery efficiency).

Read More

FUND PERFORMANCE AS OF 31st December 2025

ANNUALIZED SINCE INCEPTION QUARTERLY YTD
18.6% 4.0% 14.6%
2025 2024 2023
14.6% 7.3% 1.6%